CAPTRUST Financial Advisors’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
GW
CAPTRUST Financial Advisors's NWBO Position: Q3 2022 in Review
CAPTRUST Financial Advisors sold out of Northwest Biotherapeutics (NWBO) in Q3 2022, closing a stake of 17,624 shares — an estimated $11K sold.
CAPTRUST Financial Advisors first reported a position in NWBO in Q1 2019 and held it in 12 quarters. The position peaked at $12K in Q1 2021. 13 funds tracked by Wall St. Rank hold NWBO as of Q3 2022.
- CAPTRUST Financial Advisors reported no remaining Northwest Biotherapeutics position as of Q3 2022 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 17,624 Northwest Biotherapeutics shares in Q3 2022, an estimated $11K.
- CAPTRUST Financial Advisors first reported a position in Northwest Biotherapeutics in Q1 2019 and held it in 12 quarters.
- CAPTRUST Financial Advisors's Northwest Biotherapeutics position peaked at $12K in Q1 2021.
- 13 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q3 2022.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.